Development and validation of an LC‐MS/MS method to quantify lysergic acid diethylamide (LSD), iso‐LSD, 2‐oxo‐3‐hydroxy‐LSD, and nor‐LSD and identify novel metabolites in plasma samples in a controlled clinical trial

By  

Journal Of Clinical Laboratory Analysis (Electronic), Vol. 32, Iss. 2, 2018-02 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effect of Ca 2+ channel blockers on arterial hypertension and heart ischaemic lesions induced by chronic blockade of nitric oxide in the rat

By de Oliveira C.F.   Nathan L.P.   Metze K.   Moreno H.   de Luca I.M.S.   Sucupira M.   Zatz R.   Zappellini A.   Antunes E.   de Nucci G.  

European Journal of Pharmacology, Vol. 373, Iss. 2, 1999-06 ,pp. : 195-200

Elsevier

Access to resources Recommend Favorite

T-477, a novel Ca 2+ - and Na + channel blocker, prevents veratridine-induced neuronal injury

By Okuyama K.   Kiuchi S.   Okamoto M.   Narita H.   Kudo Y.  

European Journal of Pharmacology, Vol. 398, Iss. 2, 2000-06 ,pp. : 209-216

Elsevier

Access to resources Recommend Favorite

A Review of Lysergic Acid Diethylamide (LSD) in the Treatment of Addictions: Historical Perspectives and Future Prospects

By  

Current Drug Abuse Reviews, Vol. 7, Iss. 3, 2014-12 ,pp. : 146-156

Bentham Science Publishers

Access to resources Recommend Favorite

Characteristics of Ca 2+ channel blockade by oxodipine and elgodipine in rat cardiomyocytes

By Galan L.   Talavera K.   Vassort G.   Alvarez J.L.  

European Journal of Pharmacology, Vol. 357, Iss. 1, 1998-09 ,pp. : 93-105

Elsevier

Access to resources Recommend Favorite